jain.com

CRO Marc Boroditsky sold 7,000 shares

Company: Nebius

Subject kind
personnel
Statement date
2026-09-14
Promised amount
7000.0 shares
Current status
verified

The claim, verbatim

CRO Marc Boroditsky sold 7,000 shares at an average $209.08 ($1,463,560) under a Rule 10b5-1 plan, leaving 5,000 shares.

Source (primary)

Nebius Group (NASDAQ:NBIS) Stock Jumps 4.5% - Should You Buy? - MarketBeat (-, news_article)
View cached copy (2026-10-03)Live source ↗

Quote: “CRO Marc Boroditsky sold 7,000 shares of the stock in a transaction dated Monday, September 14th.”

How we checked this

Checked on October 12, 2026. The cited source supports every part of this claim.

The article's insider-trading section reports Boroditsky's sale of 7,000 shares at an average of $209.08 for $1,463,560 under a Rule 10b5-1 plan, leaving him with 5,000 shares. Elsewhere the article's news summary says the chief revenue officer sold his entire directly held position, which conflicts with the 5,000 shares remaining, but the detailed figures support every part of the claim.

Confirmed in the source:

What we did: Read our cached copy of the publisher (https://www.marketbeat.com/instant-alerts/price-nebius-group-nasdaq-nbis-stock-jumps-45-should-you-buy-2026-10-02/) in full (20,238 characters, retrieved October 3, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms Nebius Group (NASDAQ:NBIS) Stock Jumps 4.5% - Should You Buy? - MarketBeat

Quote: “CRO Marc Boroditsky sold 7,000 shares of the stock in a transaction dated Monday, September 14th.”

View cached copy (2026-10-03)Live source ↗

confirms Nebius Group (NASDAQ:NBIS) Shares Climb 7.4% - Here's Why - MarketBeat

Quote: “CRO Marc Boroditsky sold 7,000 shares of the firm's stock in a transaction on Monday, September 14th”

View cached copy (2026-10-07)Live source ↗Archive.org ↗

Record of changes

October 3, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 9, 2026 — verified
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.